Cargando…
Epac1 inhibits PKR to reduce NLRP3 inflammasome proteins in retinal endothelial cells
Purpose: Inflammation has been strongly associated with retinal damage in diseases such as diabetic retinopathy. Several studies have reported that high glucose exposure induces damage to the retinal vasculature. We and others have shown that high glucose can activate the NOD-like receptor family, p...
Autores principales: | Jiang, Youde, Steinle, Jena J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6580119/ https://www.ncbi.nlm.nih.gov/pubmed/31354329 http://dx.doi.org/10.2147/JIR.S210441 |
Ejemplares similares
-
Epac1 and PKA agonists inhibit ROS to reduce NLRP3 inflammasome proteins in retinal endothelial cells
por: Liu, Li, et al.
Publicado: (2022) -
PKA and Epac1 Reduce Nek7 to Block the NLRP3 Inflammasome Proteins in the Retinal Vasculature
por: Liu, Li, et al.
Publicado: (2022) -
Epac1 Blocks NLRP3 Inflammasome to Reduce IL-1β in Retinal Endothelial Cells and Mouse Retinal Vasculature
por: Jiang, Youde, et al.
Publicado: (2017) -
Epac1 agonist decreased inflammatory proteins in retinal endothelial cells, and loss of Epac1 increased inflammatory proteins in the retinal vasculature of mice
por: Liu, Li, et al.
Publicado: (2017) -
Epac1 Requires AMPK Phosphorylation to Regulate HMGB1 in the Retinal Vasculature
por: Jiang, Youde, et al.
Publicado: (2020)